Hiroshi Okuno
Papers
3
Total Citations
17
H-Index
2
About
Hiroshi Okuno is a leading urologic surgeon and researcher whose work centers on optimizing treatment strategies for prostate cancer, with a particular emphasis on cost-effectiveness, surgical outcomes, and patient safety. His most impactful contribution is a landmark 2022 study comparing the medical costs of active surveillance versus robot-assisted laparoscopic prostatectomy, brachytherapy, intensity-modulated radiation therapy, and hormone therapy for low-risk prostate cancer in Japan, using data from the PRIAS-JAPAN study. This work, cited 8 times, provides critical economic evidence to guide clinical decision-making. Okuno has also made significant contributions to understanding bleeding risks in robot-assisted radical prostatectomy, notably through a 2024 cohort study (7 citations) examining the effects of thienopyridine-class antiplatelet agents on postoperative complications. Additionally, his 2018 case report on peritoneal tuberculosis following robot-assisted laparoscopic prostatectomy with extended lymph node dissection highlights his commitment to documenting rare but serious postoperative complications. Okuno’s research directly informs urologic practice by balancing oncologic efficacy with economic and safety considerations, making him a key figure in evidence-based prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3